Non Alcoholic Fatty Liver Disease; Disease Burden, Management, and Future Perspectives
Peter Jerome Ishmael Villete Paulino, Kimberly Morton Cuthrell, Nikolaos Tzenios
International Research Journal of Gastroenterology and Hepatology · pp. 1–13 · Published 4 Jan 2024
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a significant and pertinent human ailment linked to a modified way of life, characterized by a fast increasing occurrence and prevalence in the majority of countries worldwide. Non-alcoholic fatty liver disease (NAFLD) can lead to significant health problems at various stages of chronic liver disease, including cirrhosis and related consequences such as hepatocellular carcinoma (HCC) and decompensation (such as bleeding from esophageal varices, accumulation of fluid in the abdomen, and impaired brain function due to liver dysfunction). In addition to hepatic problems, non-alcoholic fatty liver disease (NAFLD) patients frequently experience the metabolic syndrome, type 2 diabetes (T2D), and cardiovascular disease (CVD). While the current comprehension of the fundamental pathways in relation to NAFLD is growing, the precise pathophysiological impact of NAFLD on T2D and CVD remains incompletely known. One of the main theories suggests that a sub-clinical pro-inflammatory milieu is caused by lipotoxicity, insulin resistance (IR), and the intestinal microbiota. The primary foundation of the treatment involves lifestyle adjustment, which encompasses weight reduction, nutritional intervention, and consistent physical activity. While achieving this aim may be challenging for numerous patients, it is advisable for treating physicians to recommend and provide support for it. A variety of therapy choices, ranging from non-invasive management and medical intervention to surgical techniques (such as bariatric surgery), have been created with different results, particularly for the non-invasive treatment methods. The range of innovative therapeutic techniques is extensive, with several intriguing candidates. Collectively, NAFLD represents a significant healthcare concern that is projected to escalate in the future. Consequently, it is imperative for physicians from many disciplines to enhance their understanding of this condition to effectively address it with their patients.
Cited by 0
No indexed citations yet.
Related research
- Acyl-CoA:Diacylglycerol Acyltransferase: A Key Player in the Regulation of Fatty Acid and Glucose Metabolism in Mammalian Systems — shares topic coverage
- Impact of Different Dietary Components on Some Adipocytokines in Association with Obesity Related Metabolic Disorders Induced in Rats — shares topic coverage
- Serum Biochemical Alterations in Dogs Affected by Hepatic Dysfunction in Jaipur, Rajasthan, India — shares topic coverage
- Evaluating the Effectiveness of Ursodeoxycholic Acid in Various Treatment Approaches for Canine Liver Dysfunction: A Comparative Study — shares topic coverage
- Prevalence of Intestinal Helminthic Infections in Pregnant Women Attending Antenatal Clinic in Abeokuta, Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.